KUALA LUMPUR, Nov 1, 2023 – (ACN Newswire) – DC Healthcare Holdings Berhad (“DC Healthcare” or the “Company”), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, announced today the launch of ‘newB,’ a state-of-the-art skincare line developed by its subsidiary, Ten Doctors Sdn Bhd (10DRS). The new range is segmented into two categories: newB Premium Ageless and newB Premium Hydration, both formulated to set new standards in skincare efficacy.
Engineered with the revolutionary ingredient DiamondC60™, the newB Premium Ageless range delivers potent anti-ageing benefits. This ground-breaking ingredient contains Japan Quality Fullerene “The First Natural Fullerene in Malaysia directly from Japan”, exhibits superior anti-oxidative performance compared to traditional anti-ageing components like Vitamin C.
In parallel, the newB Premium Hydration collection is empowered by the innovative 7HA Boost Complex. This advanced formulation incorporates seven distinct molecular sizes of hyaluronic acid and FUCOGEL®, ensuring ultimate water-boost for lasting healthy, soft and plump skin.
Dr. Chong Tze Sheng, Managing Director of DC Healthcare, stated, “The launch of newB is a strategic move in diversifying our healthcare portfolio. Our skincare products are developed with scientific precision, catering to the evolving skincare needs of our clientele. These new product lines not only contribute to our revenue streams but also enhance our reputation as a comprehensive healthcare provider. We are particularly encouraged by the commercial applications of DiamondC60™, an ingredient that we believe will set new industry standards.”
Amid projections for the Malaysian aesthetic medicine market to register a CAGR of 18.8% from 2021 to 2027, the introduction of newB resonates with DC Healthcare’s commitment to innovation and excellence. The new skincare ranges are available for purchase through multiple online platforms, including Shopee, Lazada, TikTok shop, and Watsons Malaysia Online Store.
Moving forward, DC Healthcare will continue to focus on its core business, which includes aesthetic services and innovative healthcare solutions like newB. The Company plans to expand existing clinics, invest in cutting-edge technology, and fortify its team of medical professionals to capitalise on the growth opportunities presented by the aesthetic medicine market.
As at 31 October 2023, the share price of DC Healthcare stands at 0.52 sen per share, reflecting a market capitalisation of RM518.1 million.
For more information, please visit this LINK.
Topic: Press release summary
EW Healthcare Partners announced that it has acquired a c. 25% minority stake in Boiron Developpement, an entity formed for the purposes of launching a tender offer for the Boiron Group, in partnership with the Boiron Family, at a c. €875 million enterprise value. As part of this transaction, the Boiron family has transferred its 70% stake in the Boiron Group to Boiron Developpement, together with the Boiron employee fund for c. 5% of the capital.
Boiron is a French pharmaceutical company focused on natural medicine, founded in 1932 by pharmacists Jean and Henri Boiron. The company is built around homeopathy and has spearheaded the industry’s global development.
Boiron today is the global market leader in homeopathy and a leading global player in natural medicines, with 2022 revenues of €534M. The company offers a diversified portfolio of natural, innovative, science-based, and personalized pharmaceutical products. Over 50% of Boiron’s sales are realized outside of France. Boiron benefits from an integrated value chain from registration to distribution, including in-house manufacturing, with the company currently present in 50 countries globally through 23 subsidiaries and 30 distributors. Boiron has also established a strong footprint in the U.S. with €120M in U.S. revenue, with a large portion of products sold through the e-commerce channel.
EW Healthcare Partners is excited to partner with the Boiron family to help further accelerate the company’s growth, by expanding the company’s offering into additional healthcare verticals and capitalising on the existing platform to launch additional products, in particular in the U.S.
About EW Healthcare Partners (“EW”)
With over $2 billion of capital raised since 2014, EW Healthcare Partners seeks to make growth equity investments in fast-growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. EW Healthcare Partners has a singular commitment to the healthcare industry and has been a long-term investor in numerous healthcare companies, ranging across sectors, stages and geographies. The team of senior investment professionals, operating partners and advisors is based in New York, London and Houston. https://www.ewhealthcare.com
Anne DeMaret, Investor Relations, email@example.com (281) 528-1956
Topic: Press release summary
Avant Healthcare Professionals, the premier staffing provider of internationally experienced nursing and allied health professionals, today announced it was named among the winners of the 40th Annual Healthcare Advertising Awards, earning Gold honors for its What to Expect: The State of Nurse Staffing in 2023 blog and Top Concerns of Nurse Executives ebook. The company also received bronze honors for The Truth About the Nursing Shortage – Causes, Statistics, and Solutions blog and merit honors for its Understanding Cultural Differences in the Nursing Profession blog and 2022 Trends in Nurse Staffing Study.
This year, over 4,300 entries were received in the Healthcare Advertising Awards, making it the largest awards program of its kind. Gold awards were presented to 530 entries, silver awards to 352 entries and bronze awards to 238 entries.
In the What to Expect: The State of Nurse Staffing in 2023 blog, Avant Healthcare Professionals examines the significant changes happening in the healthcare industry since the pandemic and what healthcare facilities should expect as the future of nurse staffing. In the Top Concerns of Nurse Executives ebook, Avant covers the challenges and key issues facing nurse leaders, their impacts and the industry trends driving them. The Truth About the Nursing Shortage – Causes, Statistics, and Solutions blog highlights drivers of the nursing shortage, shortage statistics and solutions for the deficit of nurses in the U.S.
Avant Healthcare Professionals
Avant Healthcare Professionals, the premier staffing provider of internationally experienced nursing and allied health professionals, today announced that one of its international nurses, Kathlyn Buo, RN, was honored with The DAISY Award by her facility in Texas.
“Kathlyn’s recognition as a DAISY Award-winning nurse highlights the exceptional work the Avant nurses do every day – and we are delighted to celebrate this great honor with her,” shared Adam Kless, vice president, clinical operations at Avant Healthcare Professionals. “Our international nurses make significant contributions to the nursing practice, positively changing the lives of patients, coworkers and the communities they serve.”
Kathlyn Buo, RN, currently works in the PACU unit at her facility in Corpus Christi, Texas. It was her exceptional work there that led to the nomination – and her ultimately becoming a recipient of the esteemed Daisy Award. Buo demonstrated an exceptional sense of urgency in addressing a change of patient condition after surgery. She provided the surgeon with detailed information, which allowed him to rapidly diagnose and treat the patient’s condition. Her nursing knowledge, critical thinking and timely response proved to be instrumental in a positive patient outcome – and her exceptional skills were noted by the surgeon who nominated her for this prestigious nursing honor.
The DAISY Foundation was formed in 1999 by the family of J. Patrick Barnes, who succumbed to complications of Idiopathic Thrombocytopenic Purpura (ITP) at the age of 33. The nursing care Patrick received when hospitalized profoundly touched him and his family. Today, The DAISY Foundation proudly honors nurses wherever they practice, in whatever role they serve, and throughout their careers – from nursing students through lifetime achievement.
To nominate a nurse, for a Daisy Award, visit: www.daisyfoundation.org/daisy-award/thank-your-nurse-nomination.
Avant Healthcare Professionals
DC Healthcare Holdings Berhad, an established aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, launched the prospectus today in conjunction with the Group’s initial public offering (IPO) on the ACE Market of Bursa Malaysia Securities Berhad.
The IPO will raise RM49.81 million via the issuance of 199.26 million new shares at the IPO price of RM0.25 per share to fund DC Healthcare’s growth plans as well as working capital and repayment of borrowings. The proceeds will be used in the following manner:
– RM9.44 million to establish aesthetic medical clinics
– RM13.12 million to purchase medical machinery and equipment
– RM6.24 million to repay borrowings
– RM17.01 million for working capital, including staff salaries as well as medical supplies and consumables
– RM4.00 million for estimated listing expenses
Managing Director of DC Healthcare, Dr. Chong Tze Sheng said, “DC Healthcare’s expansion plan is based on demand for aesthetic medical services as people are becoming more aware on skin health, as well as wanting to look and feel good about themselves, especially in the long run. It is projected that aesthetic medical services and general medical services related to skin disease will increase due to people having more disposable income for discretionary spending and becoming better educated on skin conditions.”
Mr. Danny Wong, Deputy Head of Corporate Finance, of M&A Securities Sdn Bhd said, “The Malaysian market for aesthetic medical services will continue to grow supported by demand as incomes rise and populations aged. This will be helped along by the increased consumerism and growing influence of social media removing the stigma of aesthetic medical procedures. With the growing acceptance of such treatments, the domestic aesthetic medical services market is projected to have a compound annual growth rate of 18.8% from 2021 to 2027 valuing the total market at RM1.03 billion.”
DC Healthcare – or famously known ‘Dr. Chong Clinic’ or ‘Klinik Dr. Chong’ – provides aesthetic services, general medical services and sale of skincare products. DC Healthcare currently has 13 clinics and 10 LCP Certified Aesthetic Physicians, assisted by 29 resident medical doctors in the central and southern regions of Peninsular Malaysia namely in Negeri Sembilan, Selangor, Johor, and Kuala Lumpur.
For the financial year ended 31 December 2022 (FYE2022), the Group recorded revenue of RM51.96 million compared with RM25.48 million in FYE2021 with a net profit margin of 18.40% and 18.06% respectively.
Aesthetic services contributed 89.96% to total revenue for FYE2022 and 84.88% in FYE2021, compared to general medical services who contributed 10.04% in FYE2022 and 15.12% in FYE2021.
In addition, for the financial year ended 31 December 2020 (FYE2020) and 31 December 2019 (FYE2019), DC Healthcare registered revenue RM14.45 million and RM12.21 million respectively. Aesthetic services contributed 89.80% in FYE2019 and 87.50% in FYE2020 to the total revenue, while general medical services contributed 10.20% in FYE2019 and 12.50% in FYE2020.
DC Healthcare Holdings Berhad: http://dchealthcareholdings.com/
DR. CHONG TZE SHENG, Managing Director; DATUK BILL TAN, Managing Director of Corporate Finance, M&A Securities Sdn Bhd [L-R]( https://photos.acnnewswire.com/tr:n-650/2023627.DCHealthcare1.jpg )
1. Mr. Lee Yoke Wah, Associate Director of Corporate Finance, M&A Securities Sdn Bhd
2. Ms. Sim Lee San, Independent Non-Executive Director, DC Healthcare Holdings Berhad
3. Ms. Rekha A/P Palanysamy, Independent Non-Executive Director, DC Healthcare Holdings Berhad
4. Datuk Dr Mohd Noor Bin Awang, Independent Non-Executive Chairman, DC Healthcare Holdings Berhad
5. Dr. Chong Tze Sheng, Managing Director, DC Healthcare Holdings Berhad
6. Datuk Bill Tan, Managing Director of Corporate Finance, M&A Securities Sdn Bhd
7. Dr. Lai Ngan Chee, Executive Director, DC Healthcare Holdings Berhad
8. Ms. Yap Ee Ling, Independent Non-Executive Director, DC Healthcare Holdings Berhad
9. Mr. Danny Wong, Deputy Head of Corporate Finance, M&A Securities Sdn Bhd [L-R]( https://photos.acnnewswire.com/tr:n-650/2023627.DCHealthcare2.jpg )
Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.